A1C: Episode 3.
作者信息
Aung Nay Linn
机构信息
Mohawk Valley Health System, Utica, NY.
出版信息
Clin Diabetes. 2024 Summer;42(3):448-451. doi: 10.2337/cd24-0038. Epub 2024 May 2.
Abstract
摘要
相似文献
1
A1C: Episode 3.糖化血红蛋白：第3集。
Clin Diabetes. 2024 Summer;42(3):448-451. doi: 10.2337/cd24-0038. Epub 2024 May 2.
2
Preoperative Hemoglobin A1c >7.5 Is Associated With Increased Bundled Payment Costs in Total Hip and Knee Arthroplasties.术前糖化血红蛋白 A1c>7.5 与全髋关节和膝关节置换术捆绑支付费用增加相关。
J Am Acad Orthop Surg. 2021 Nov 15;29(22):970-976. doi: 10.5435/JAAOS-D-20-00944.
3
Effects of Glucose Fluctuation Targeted Intervention on the Prognosis of Patients with Type 2 Diabetes following the First Episode of Cerebral Infarction.血糖波动目标干预对首发脑梗死的 2 型糖尿病患者预后的影响。
J Diabetes Res. 2020 Jan 28;2020:2532171. doi: 10.1155/2020/2532171. eCollection 2020.
4
A1C: Episode 2.糖化血红蛋白：第2集。
Clin Diabetes. 2024 Spring;42(2):333-336. doi: 10.2337/cd24-0009. Epub 2024 Feb 12.
5
A1C: Episode 1.糖化血红蛋白：第1集。
Clin Diabetes. 2024 Winter;42(1):165-168. doi: 10.2337/cd23-0084. Epub 2023 Oct 24.
6
Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*.维格列汀在初治2型糖尿病合并轻度高血糖患者中的疗效和耐受性*
Diabetes Obes Metab. 2008 Aug;10(8):675-82. doi: 10.1111/j.1463-1326.2008.00850.x. Epub 2007 Nov 22.
7
Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use.即时 HbA1c 在临床实践中的应用：注意事项和最佳使用的考虑因素。
Diabetes Care. 2024 Jul 1;47(7):1104-1110. doi: 10.2337/dci23-0040.
8
Hb A1c Separation by High Performance Liquid Chromatography in Hemoglobinopathies.血红蛋白病中通过高效液相色谱法分离糖化血红蛋白A1c
Scientifica (Cairo). 2016;2016:2698362. doi: 10.1155/2016/2698362. Epub 2016 Feb 16.
9
Correlation Between A1c and Continuous Glucose Monitor Time in Range in a Cohort of Pediatric Patients with Type 1 Diabetes.1型糖尿病儿科患者队列中糖化血红蛋白（A1c）与血糖监测达标时间的相关性
Diabetes Technol Ther. 2025 Jul;27(7):567-571. doi: 10.1089/dia.2024.0500. Epub 2025 Feb 12.
10
Limitations of A1c Interpretation.糖化血红蛋白（A1c）解读的局限性。
South Med J. 2015 Dec;108(12):724-9. doi: 10.14423/SMJ.0000000000000381.
引用本文的文献
1
Random Blood Glucose: Episode 2.随机血糖：第2集。
Clin Diabetes. 2025 Apr 29;43(3):435-438. doi: 10.2337/cd25-0044. eCollection 2025 Summer.
2
Random Blood Glucose: Episode 1.随机血糖：第1集。
Clin Diabetes. 2025 Feb 12;43(2):317-321. doi: 10.2337/cd25-0016. eCollection 2025 Spring.
3
Postprandial Plasma Glucose.餐后血糖
Clin Diabetes. 2024 Nov 7;43(1):161-164. doi: 10.2337/cd24-0099. eCollection 2025 Winter.
4
Plasma Glucose.血浆葡萄糖
Clin Diabetes. 2024 Aug 7;42(4):574-578. doi: 10.2337/cd24-0074. eCollection 2024 Fall.
本文引用的文献
1
A1C: Episode 2.糖化血红蛋白：第2集。
Clin Diabetes. 2024 Spring;42(2):333-336. doi: 10.2337/cd24-0009. Epub 2024 Feb 12.
2
A1C: Episode 1.糖化血红蛋白：第1集。
Clin Diabetes. 2024 Winter;42(1):165-168. doi: 10.2337/cd23-0084. Epub 2023 Oct 24.
3
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2022 年美国糖尿病协会 (ADA) 和欧洲糖尿病研究协会 (EASD) 共识报告：2 型糖尿病患者高血糖管理。
Diabetes Care. 2022 Nov 1;45(11):2753-2786. doi: 10.2337/dci22-0034.
4
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.替尔泊肽与司美格鲁肽每周一次治疗 2 型糖尿病患者的疗效比较。
N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25.
5
Sodium-glucose cotransporter 2 inhibitors as an add-on therapy to insulin for type 1 diabetes mellitus: Meta-analysis of randomized controlled trials.钠-葡萄糖共转运蛋白 2 抑制剂作为 1 型糖尿病胰岛素的附加治疗：随机对照试验的荟萃分析。
Acta Diabetol. 2021 Jul;58(7):869-880. doi: 10.1007/s00592-021-01686-x. Epub 2021 Mar 2.
6
HbA Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression.GLP-1 受体激动剂心血管结局试验中 HbA 变化与糖尿病视网膜病变：荟萃分析和荟萃回归。
Diabetes Care. 2021 Jan;44(1):290-296. doi: 10.2337/dc20-1815.
7
A Model-Based Meta-Analysis of 24 Antihyperglycemic Drugs for Type 2 Diabetes: Comparison of Treatment Effects at Therapeutic Doses.基于模型的 24 种抗 2 型糖尿病药物的荟萃分析：治疗剂量下的治疗效果比较。
Clin Pharmacol Ther. 2019 May;105(5):1213-1223. doi: 10.1002/cpt.1307. Epub 2019 Jan 13.
8
Efficacy and safety of pramlintide injection adjunct to insulin therapy in patients with type 1 diabetes mellitus: a systematic review and meta-analysis.普兰林肽注射液辅助胰岛素治疗1型糖尿病患者的疗效和安全性：一项系统评价和荟萃分析。
Oncotarget. 2017 Mar 8;8(39):66504-66515. doi: 10.18632/oncotarget.16008. eCollection 2017 Sep 12.
9
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial.每周一次司美格鲁肽单药治疗与安慰剂在 2 型糖尿病患者中的疗效和安全性（SUSTAIN 1）：一项双盲、随机、安慰剂对照、平行分组、多国、多中心 3a 期临床试验。
Lancet Diabetes Endocrinol. 2017 Apr;5(4):251-260. doi: 10.1016/S2213-8587(17)30013-X. Epub 2017 Jan 17.
10
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial.利拉鲁肽联合胰岛素治疗 1 型糖尿病的疗效和安全性：ADJUNCT ONE 达标随机临床试验。
Diabetes Care. 2016 Oct;39(10):1702-10. doi: 10.2337/dc16-0691. Epub 2016 Aug 9.
Zotero 插件